Alteration of fecal microbiota by fucoxanthin results in prevention of colorectal cancer in AOM/DSS mice. (17th September 2020)
- Record Type:
- Journal Article
- Title:
- Alteration of fecal microbiota by fucoxanthin results in prevention of colorectal cancer in AOM/DSS mice. (17th September 2020)
- Main Title:
- Alteration of fecal microbiota by fucoxanthin results in prevention of colorectal cancer in AOM/DSS mice
- Authors:
- Terasaki, Masaru
Uehara, Osamu
Ogasa, Shinya
Sano, Taishi
Kubota, Atsuhito
Kojima, Hiroyuki
Tanaka, Takuji
Maeda, Hayato
Miyashita, Kazuo
Mutoh, Michihiro - Abstract:
- Abstract: Fucoxanthin (Fx), a marine carotenoid found in edible brown algae, is well known for having anticancer properties. The gut microbiota has been demonstrated as a hallmark for colorectal cancer progression in both humans and rodents. However, it remains unclear whether the gut microbiota is associated with the anticancer effect of Fx. We investigated the chemopreventive potency of Fx and its effect on gut microbiota in a mouse model of inflammation-associated colorectal cancer (by azoxymethane/dextran sulfate sodium treatment). Fx administration (30 mg/kg bw) during a 14 week period significantly inhibited the multiplicity of colorectal adenocarcinoma in mice. The number of apoptosis-like cleaved caspase-3 high cells increased significantly in both colonic adenocarcinoma and mucosal crypts. Fx administration significantly suppressed Bacteroidlales (f_uc; g_ uc) (0.3-fold) and Rikenellaceae ( g_ uc) (0.6-fold) and increased Lachnospiraceae ( g_ uc) (2.2-fold), compared with those of control mice. Oral administration of a fecal suspension obtained from Fx-treated mice, aimed to enhance Lachnospiraceae, suppress the number of colorectal adenocarcinomas in azoxymethane/dextran sulfate sodium-treated mice with a successful increase in Lachnospiraceae in the gut. Our findings suggested that an alteration in gut microbiota by dietary Fx might be an essential factor in the cancer chemopreventive effect of Fx in azoxymethane/dextran sulfate sodium-treated mice. Abstract :Abstract: Fucoxanthin (Fx), a marine carotenoid found in edible brown algae, is well known for having anticancer properties. The gut microbiota has been demonstrated as a hallmark for colorectal cancer progression in both humans and rodents. However, it remains unclear whether the gut microbiota is associated with the anticancer effect of Fx. We investigated the chemopreventive potency of Fx and its effect on gut microbiota in a mouse model of inflammation-associated colorectal cancer (by azoxymethane/dextran sulfate sodium treatment). Fx administration (30 mg/kg bw) during a 14 week period significantly inhibited the multiplicity of colorectal adenocarcinoma in mice. The number of apoptosis-like cleaved caspase-3 high cells increased significantly in both colonic adenocarcinoma and mucosal crypts. Fx administration significantly suppressed Bacteroidlales (f_uc; g_ uc) (0.3-fold) and Rikenellaceae ( g_ uc) (0.6-fold) and increased Lachnospiraceae ( g_ uc) (2.2-fold), compared with those of control mice. Oral administration of a fecal suspension obtained from Fx-treated mice, aimed to enhance Lachnospiraceae, suppress the number of colorectal adenocarcinomas in azoxymethane/dextran sulfate sodium-treated mice with a successful increase in Lachnospiraceae in the gut. Our findings suggested that an alteration in gut microbiota by dietary Fx might be an essential factor in the cancer chemopreventive effect of Fx in azoxymethane/dextran sulfate sodium-treated mice. Abstract : Fucoxanthin altered gut microbiota with chemoprevention of inflammation-associated colorectal cancer in azoxymethane/dextran sulfate sodium-treated mice. Lachnospiraceae and Rikenellaceae are chemopreventive indictors in mice treated with Fucoxanthin. Administration of feces from Fucoxanthin-treated azoxymethane/dextran sulfate sodium-treated mice prevented mouse colorectal cancer. … (more)
- Is Part Of:
- Carcinogenesis. Volume 42:Number 2(2021)
- Journal:
- Carcinogenesis
- Issue:
- Volume 42:Number 2(2021)
- Issue Display:
- Volume 42, Issue 2 (2021)
- Year:
- 2021
- Volume:
- 42
- Issue:
- 2
- Issue Sort Value:
- 2021-0042-0002-0000
- Page Start:
- 210
- Page End:
- 219
- Publication Date:
- 2020-09-17
- Subjects:
- Carcinogenesis -- Periodicals
Cancer -- Genetic aspects -- Periodicals
Cancer -- Prevention -- Periodicals
Cancer -- Periodicals
616.994071 - Journal URLs:
- http://carcin.oupjournals.org ↗
http://carcin.oxfordjournals.org ↗
http://www.ingenta.com/journals/browse/oup/carcin?mode=direct ↗
http://ukcatalogue.oup.com/ ↗
http://firstsearch.oclc.org ↗ - DOI:
- 10.1093/carcin/bgaa100 ↗
- Languages:
- English
- ISSNs:
- 0143-3334
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3051.007000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 15934.xml